Clinical Pediatric Emergency Medicine
Volume 8, Issue 3 , Pages 145-155 , September 2007

Emergency Care for Infants and Children with Acute Cardiac Disease

  • John M. Costello, MD

      Affiliations

    • Division of Cardiac Intensive Care, Department of Cardiology, Children's Hospital Boston, Boston, MA
    • Department of Pediatrics, Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests and correspondence: John M. Costello, MD, Cardiac Intensive Care Unit, Division of Cardiac Intensive Care, Children's Hospital Boston, 300 Longwood Avenue, FA-105, Boston, MA 02115-5724.
    • ,
  • Melvin C. Almodovar, MD

      Affiliations

    • Division of Cardiac Intensive Care, Department of Cardiology, Children's Hospital Boston, Boston, MA
    • Department of Pediatrics, Harvard Medical School, Boston, MA

References 

  1. Pediatric advanced life support. Circulation. 2005;112:IV-167–IV-187
  2. Heymann MA, Berman W, Rudolph AM, et al. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities. Circulation. 1979;59:169–173
  3. Neutze JM, Starling MB, Elliott RB, et al. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins. Circulation. 1977;55:238–241
  4. Kramer HH, Sommer M, Rammos S, et al. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease. Eur J Pediatr. 1995;154:700–707
  5. Hallidie-Smith KA. Prostaglandin E1 in suspected ductus dependent cardiac malformation. Arch Dis Child. 1984;59:1020–1026
  6. Lewis AB, Freed MD, Heymann MA, et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981;64:893–898
  7. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. JAMA. 1966;196:991–992
  8. Ashfaq M, Houston AB, Gnanapragasam JP, et al. Balloon atrial septostomy under echocardiographic control: six years' experience and evaluation of the practicability of cannulation via the umbilical vein. Br Heart J. 1991;65:148–151
  9. Barnea O, Austin EH, Richman B, et al. Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J Am Coll Cardiol. 1994;24:1376–1381
  10. Yeager SB, Horbar JD, Greco KM, et al. Pretransport and posttransport characteristics and outcomes of neonates who were admitted to a cardiac intensive care unit. Pediatrics. 2006;118:1070–1077
  11. Johnsrude CL, Perry JC, Cecchin F, et al. Differentiating anomalous left main coronary artery originating from the pulmonary artery in infants from myocarditis and dilated cardiomyopathy by electrocardiogram. Am J Cardiol. 1995;75:71–74
  12. Walsh EP, Saul JP, Hulse JE, et al. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation. 1992;86:1138–1146
  13. Naheed ZJ, Strasburger JF, Benson DW, et al. Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol. 1995;75:405–407
  14. Shekerdemian L, Bohn D. Acute viral myocarditis: epidemiology and pathophysiology. Pediatr Crit Care Med. 2006;7::S2–S7
  15. Checchia PA, Kulik TJ. Acute viral myocarditis: diagnosis. Pediatr Crit Care Med. 2006;7:S8–S11
  16. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–1258[Electronic publication 2004 Mar 1]
  17. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466–472
  18. Pahl E, Naftel DC, Canter CE, et al. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. J Heart Lung Transplant. 2001;20:279–287
  19. Publication Committee for the VMAC Investigators . Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531–1540
  20. Jefferies JL, Denfield SW, Price JF, et al. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006;27:402–407
  21. Mahle WT, Cuadrado AR, Kirshborn PM, et al. Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med. 2005;6:543–546
  22. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89:252–257
  23. Duncan BW, Bohn DJ, Atz AM, et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001;122:440–448
  24. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690–695
  25. Costello JM, Pahl E. Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients. Paediatr Drugs. 2002;4:705–715
  26. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349:684–690
  27. Divekar A, Gaamangwe T, Shaikh N, et al. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol. 2005;45:1213–1218
  28. Scarfone RJ, Donoghue AJ, Alessandrini EA. Cardiac tamponade complicating postpericardiotomy syndrome. Pediatr Emerg Care. 2003;19:268–271
  29. Lock JE, Bass JL, Kulik TJ, et al. Chronic percutaneous pericardial drainage with modified pigtail catheters in children. Am J Cardiol. 1984;53:1179–1182

PII: S1522-8401(07)00032-8

doi: 10.1016/j.cpem.2007.06.005

Clinical Pediatric Emergency Medicine
Volume 8, Issue 3 , Pages 145-155 , September 2007

Article Tools

* Image Usage & Resolution